Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for Infusion
Marco Donia, Morten Hansen, Sarah Louise Sendrup, et al.
Journal of Investigative Dermatology (2012) Vol. 133, Iss. 2, pp. 545-552
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment
Sine Reker Hadrup, Marco Donia, Per thor Straten
Cancer Microenvironment (2012) Vol. 6, Iss. 2, pp. 123-133
Open Access | Times Cited: 290
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
Rikke Andersen, Marco Donia, Eva Ellebæk, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 15, pp. 3734-3745
Open Access | Times Cited: 270
The untold story of IFN-γ in cancer biology
M. Alper Kursunel, Güneş Esendağlı
Cytokine & Growth Factor Reviews (2016) Vol. 31, pp. 73-81
Closed Access | Times Cited: 164
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity
Marco Donia, Rikke Andersen, Julie Westerlin Kjeldsen, et al.
Cancer Research (2015) Vol. 75, Iss. 18, pp. 3747-3759
Open Access | Times Cited: 113
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
Nikolaj Pagh Kristensen, Christina Heeke, Siri Tvingsholm, et al.
Journal of Clinical Investigation (2021) Vol. 132, Iss. 2
Open Access | Times Cited: 94
Plug-and-Play Nanorization of Coarse Black Phosphorus for Targeted Chemo-photoimmunotherapy of Colorectal Cancer
Wenquan Ou, Jeong Hoon Byeon, Raj Kumar Thapa, et al.
ACS Nano (2018) Vol. 12, Iss. 10, pp. 10061-10074
Closed Access | Times Cited: 89
γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells
Kok Fei Chan, Jessica Da Gama Duarte, Simone Ostrouska, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 46
BRAF inhibition improves tumor recognition by the immune system
Marco Donia, Paolo Fagone, Ferdinando Nicoletti, et al.
OncoImmunology (2012) Vol. 1, Iss. 9, pp. 1476-1483
Open Access | Times Cited: 79
Trial Watch
Erika Vacchelli, Alexander Eggermont, Wolf H. Fridman, et al.
OncoImmunology (2013) Vol. 2, Iss. 5, pp. e24238-e24238
Open Access | Times Cited: 76
T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma—Implications for Adoptive Cell Therapy
Rikke Andersen, Marie Christine Wulff Westergaard, Julie Westerlin Kjeldsen, et al.
Cancer Immunology Research (2018) Vol. 6, Iss. 2, pp. 222-235
Open Access | Times Cited: 68
CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer
Christina Friese, Katja Harbst, Troels Holz Borch, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 56
Materials based tumor immunotherapy vaccines
Aileen W. Li, David Mooney
Current Opinion in Immunology (2013) Vol. 25, Iss. 2, pp. 238-245
Open Access | Times Cited: 58
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?
Inge Marie Svane, Els M.E. Verdegaal
Cancer Immunology Immunotherapy (2014) Vol. 63, Iss. 10, pp. 1081-1091
Closed Access | Times Cited: 44
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling
Marco Donia, Katja Harbst, Marit van Buuren, et al.
Cancer Research (2017) Vol. 77, Iss. 17, pp. 4562-4566
Open Access | Times Cited: 41
IFN-γ Approaches in Tumor Suppression, Its Challenges, and Future Directions: A Review of Recent Advances
Mohammad Reza Ataherian, Nasim Hafezi, Elaheh Ferdosi-Shahandashti, et al.
Journal of Interferon & Cytokine Research (2025)
Closed Access
Dual role of interferon-gamma in the response of melanoma patients to immunotherapy with immune checkpoint inhibitors
Piotr Wawrzyniak, Mariusz L. Hartman
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes
Marco Donia, Eva Ellebæk, Mads Hald Andersen, et al.
OncoImmunology (2012) Vol. 1, Iss. 8, pp. 1297-1304
Open Access | Times Cited: 44
Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
Arianna Draghi, Mario Presti, Agnete W.P. Jensen, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 19, pp. 3937-3947
Open Access | Times Cited: 10
Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential
Eric Jou
Exploration of Targeted Anti-tumor Therapy (2023), pp. 474-497
Open Access | Times Cited: 10
Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways
Signe K. Skadborg, Simone Maarup, Arianna Draghi, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 9, pp. 1202-1220
Open Access | Times Cited: 3
Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
Jon Bjoern, Rikke Lyngaa, Rikke Andersen, et al.
Oncotarget (2017) Vol. 8, Iss. 16, pp. 27062-27074
Open Access | Times Cited: 29
Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients
Amir Khammari, Jean‐Michel Nguyen, M. Saint‐Jean, et al.
Cancer Immunology Immunotherapy (2015) Vol. 64, Iss. 7, pp. 805-815
Open Access | Times Cited: 28
Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma
Katherine Woods, Ashley Knights, Matthew Anaka, et al.
Journal for ImmunoTherapy of Cancer (2016) Vol. 4, Iss. 1
Open Access | Times Cited: 26
Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma Cancers Compared to Melanoma
Aishwarya Gokuldass, Arianna Draghi, Krisztián Papp, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3344-3344
Open Access | Times Cited: 22
Local immune response depends on p16INK4a status of primary tumor in vulvar squamous cell carcinoma
Jacek Jan Sznurkowski, Anton Żawrocki, Wojciech Biernat
Oncotarget (2017) Vol. 8, Iss. 28, pp. 46204-46210
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top